Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib in PF-CMD-ILD
NCT05067517Phase 3Withdrawn
- Sponsor
- West Virginia University
- Start
- Nov 2021
- Primary completion
- Jul 2024
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 3 trial of nintedanib in coal workers' pneumoconiosis (CWP), sponsored by West Virginia University. Planned start Nov 2021; status: withdrawn.
02
Drugs
nintedanib
03
Conditions
coal workers' pneumoconiosis (CWP)
Beyond the preview
Go deeper on NCT05067517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05067517.